Terms of Use
These Terms of Use govern your access to and use of ablaview.com and any content, downloads, forms, or communications associated with the site. By accessing the site you agree to be bound by these Terms. If you do not agree, please do not use the site.
1. Intended audience
ablaview.com is intended for qualified healthcare professionals, hospital administrators, payors, regulators, institutional and accredited investors, research partners, and members of the press. Content is not intended for patients, the general public, or individuals seeking medical advice. Some content may be restricted by your jurisdiction. You are responsible for ensuring that your access to this site is lawful where you are.
2. Medical and clinical disclaimer
The AblaView® PS-OCR cardiac ablation guidance system is an investigational medical device under preclinical and clinical investigation. It is not FDA approved nor CE labelled. It is not approved for sale in the United States, European Union, or any other jurisdiction. Nothing on this site constitutes medical advice, recommends a particular course of treatment, or substitutes for the independent judgement of a qualified clinician. Clinical results referenced on the site are from peer-reviewed publications and are subject to the limitations, exclusion criteria, and statistical caveats described in the original sources.
3. Investor and forward-looking statements
Information presented under /investors includes projections, milestones, target dates, market sizing, reimbursement assumptions, comparable transactions, and other forward-looking statements that reflect management’s current expectations. Such statements involve known and unknown risks, uncertainties, and assumptions, and actual outcomes may differ materially. No statement on this site constitutes an offer to sell, or a solicitation of an offer to buy, any security in any jurisdiction. Any investment opportunity is offered only through definitive documentation made available exclusively to qualified investors under a non-disclosure agreement.
4. Intellectual property
All trademarks, service marks, trade names, logos, text, graphics, photographs, video, code, and other content on this site are owned by AblaView S.L. or its licensors and are protected by Spanish, European Union, and international intellectual property laws. AblaView® is a registered trademark of AblaView S.L. The patent portfolio is enumerated in part at /investors#ip-portfolio. Nothing on this site grants any licence to use any intellectual property without prior written consent.
5. Acceptable use
You agree not to:
- Reproduce, redistribute, or republish substantial portions of the site without written permission, beyond fair-dealing exceptions in your jurisdiction.
- Attempt to access non-public areas, probe for vulnerabilities outside the scope described in /.well-known/security.txt, or interfere with site availability.
- Misrepresent your affiliation when submitting a contact form or other communication.
- Use scraped content to train a commercial product without complying with our directives in /robots.txt and any future text-and-data-mining opt-out we may publish under Article 4 of EU Directive 2019/790.
6. Third-party links
The site links to external resources, including peer-reviewed journals, clinical trial registries, and regulatory agencies. AblaView does not control these resources, does not endorse their content, and is not responsible for their availability or accuracy.
7. Warranties and liability
The site is provided on an “as is” and “as available” basis. To the maximum extent permitted by applicable law, AblaView disclaims all warranties, express or implied, including merchantability, fitness for a particular purpose, and non-infringement. AblaView will not be liable for indirect, incidental, consequential, special, or exemplary damages arising out of or in connection with the use of, or inability to use, the site. Nothing in these Terms limits liability that cannot be limited under applicable law, including liability for fraud, gross negligence, death, or personal injury caused by negligence.
8. Privacy and cookies
Personal data is processed in accordance with our Privacy Policy. Client-side storage is described in our Cookie Policy.
9. Governing law and jurisdiction
These Terms are governed by the laws of the Kingdom of Spain. Any dispute arising out of or relating to the site or these Terms is subject to the exclusive jurisdiction of the courts of Madrid, Spain, without prejudice to any mandatory consumer or data-subject forum rules.
10. Changes
We may revise these Terms from time to time. The current version is the one shown on this page. Material changes will be announced on the site. Continued use after a revision constitutes acceptance.
11. Contact
Questions: legal@ablaview.com. Postal correspondence may be sent to AblaView S.L. at the address listed in our Legal Notice.